DOI:
10.1055/s-00000134
Diabetologie und Stoffwechsel
Ausgabe 01 ·
Volume 20 ·
Februar 2025
·
Kostenlose Probeausgabe
DOI: 10.1055/s-015-61002
Erratum
e1
Aberle, Jens;
Blüher, Matthias;
Laudes, Matthias;
Merkel, Martin;
Sandow, Petra:
Correction: SGLT-2 inhibitors – An assessment of the German oral therapeutic landscape for people with type 2 diabetes
Editorial
7
Gallwitz, Baptist;
Müssig, Karsten;
Ritzel, Robert A.;
Seufert, Jochen;
Weigert, Cora:
45
Ebert, Thomas;
Guthoff, Martina;
Merker, Ludwig;
Mertens, Peter R.;
Schott, Gabriele;
Wanner, Christoph:
Danksagung
8
Für Sie referiert
9
9
10
11
12
12
13
14
15
16
17
17
18
19
20
20
22
22
ViewPoint Diabetesberatung
24
Neues aus dem DZD
27
DDG-Nachwuchs
29
Spies, Rebecca;
Bischof, Franziska;
Laaser, Jonas;
Schürmann, Annette;
Woitek, Cornelia;
Drozd, Irena;
Seufert, Jochen:
CME-Fortbildung
31
Meitner-Schellhaas, Barbara;
Haak, Thomas:
SGLT2-inhibitor-induced diabetic ketoacidosis
Leitlinie
47
Rossing, Peter;
Caramori, M. L.;
Chan, Juliana C.N.;
Heerspink, Hiddo J.L.;
Hurst, Clint;
Khunti, Kamlesh;
Liew, Adrian;
Michos, Erin D.;
Navaneethan, Sankar D.;
Olowu, Wasiu A.;
Sadusky, Tami;
Tandon, Nikhil;
Tuttle, Katherine R.;
Wanner, Christoph;
Wilkens, Katy G.;
Zoungas, Sophia;
Craig, Jonathan C.;
Tunnicliffe, David J.;
Tonelli, Marcello A.;
Cheung, Michael;
Earley, Amy;
de Boer, Ian H.:
Executive Summary of the KDIGO 2022 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease: An Update Based on New Evidence
Übersicht
59
Aberle, Jens;
Blüher, Matthias;
Laudes, Matthias;
Merkel, Martin;
Sandow, Petra:
SGLT-2 inhibitors – An assessment of the German oral therapeutic landscape for people with type 2 diabetes
